Pediat. Res. 12: 708-7 10 (1978) Testosterone concentrations were nleasured by radioimmunoassay in 57 anlniotic fluid sanlples obtained from 43 women whose gestational ages varied from 14-40 weeks. These women Irere grouped according to the sex of the fetus and the gestational age at the time of amniocentesis: group I, less than 20 weeks; group 11, 21-30 weeks; group 111, 31-40 weeks. In each gestational age group, mean testosterone concentrations were signilicantly higher in women bearing male fetuses. Of the 14 patients conlprising group 1,8 bore male fetuses. The mean testosterone concentration for nlale fetuses in this group was 198.7 pg/ml (range 93-319.8 pg/ml) and 74.1 pg/ml for female fetuses (range 39-122.8 pg/n~l). Croup 11 was comprised of 23 patients, 13 of whom bore nlale fetuses. The mean testosterone concentration for male fetuses was 221.5 pg/ml (range 133.6-395.0 pg/ml). and for female fetuses it was 67.7 pg/ml (range 35.6-103.0 pg/ml). Group I11 consisted of 20 patients of whom 10 bore male fetuses. The mean testosterone concentration for the male fetuses was 149.1 pg/ml (range 99.2-262.0 pg/nll), and for female fetuses it was 60.2 pg/ml (range 39.5-%.7 pg/n~l). Some overlapping of individual testosterone values was observed in fluid from male and female fetuses; however, the percentage of women bearing males and having aniniotic fluid testosterone concentrations greater than 100 pg/ml was 93.5% (29/31). The percentage of women bearing fenlales with testosterone concentrations less than 100 pg/nll was 88.5% (23/ 26).
Summary attributable to increased concentrations of testosterone-estradiol
Testosterone concentrations were nleasured by radioimmunoassay in 57 anlniotic fluid sanlples obtained from 43 women whose gestational ages varied from 14-40 weeks. These women Irere grouped according to the sex of the fetus and the gestational age at the time of amniocentesis: group I, less than 20 weeks; group 11, 21-30 weeks; group 111, 31-40 weeks. In each gestational age group, mean testosterone concentrations were signilicantly higher in women bearing male fetuses. Of the 14 patients conlprising group 1,8 bore male fetuses. The mean testosterone concentration for nlale fetuses in this group was 198.7 pg/ml (range 93-319.8 pg/ml) and 74.1 pg/ml for female fetuses (range 39-122.8 pg/n~l). Croup 11 was comprised of 23 patients, 13 of whom bore nlale fetuses. The mean testosterone concentration for male fetuses was 221.5 pg/ml (range 133.6-395.0 pg/ml). and for female fetuses it was 67.7 pg/ml (range 35.6-103.0 pg/ml). Group I11 consisted of 20 patients of whom 10 bore male fetuses. The mean testosterone concentration for the male fetuses was 149.1 pg/ml (range 99.2-262.0 pg/nll), and for female fetuses it was 60.2 pg/ml (range 39.5-%.7 pg/n~l). Some overlapping of individual testosterone values was observed in fluid from male and female fetuses; however, the percentage of women bearing males and having aniniotic fluid testosterone concentrations greater than 100 pg/ml was 93.5% (29/31). The percentage of women bearing fenlales with testosterone concentrations less than 100 pg/nll was 88.5% (23/ 26).
Speculation
Amniotic fluid testosterone concentrations 1:ave proven useful for the antenatal diagnosis of fetal sex. Correlation between the fetal sex based upon testosterone analysis and the amniotic fluid karyotype increases the probability that the cultured cells are of fetal origin. Certainty of diagnosis could be increased even further by combining antenatal ses diagnosis with fluorescent Y-chromatin screening of uncultured amniotic fluid. A conibination of these techniques should aid in the elimination of diagnostic errors arising from contamination by maternal cells.
Testosterone is synthesized in the gonads of the male fetus at the time of sexual differentiation and also in small amounts in the adrenal glands of both male and female fetuses (6. 7, 9) . No quantitative differences in adrenal gland synthesis are attributable to the sex of the fetus (6). Testosterone synthesis by fetal testicular tissue from precursor progesterone and pregnenolone has been demonstrated as early as 8-10 weeks of fetal age (9) : the maximum rate of synthesis was observed from tissues obtained between 17-21 weeks of fetal age after which the rate of synthesis expressed per testis declined (9) . Testosterone concentration in sera of male fetuses was found to be maximum at 11-17 weeks of gestation (1, 5): thereafter, testosterone concentration declined to a level indistinguishable from that of female fetuses.
Higher testosterone levels measured in maternal plasma compared with levels found in plasma of nonpregnant females are binding globulin (TeBG) (2, 3) , which is capable of specifically binding approximately 97% of the testosterone circulating during pregnancy (8) . Maternal plasma testosterone levels have been shown not to differ significantly according to fetal sex (8) . I t is expected that amniotic fluid testosterone would be derived from the maternal circulation and from direct contributions of the fetus. Accordingly, significant differences in the magnitude of fetal gonadal testosterone production should be reflected in amniotic fluid levels even though differences are not apparent in the maternal circulation. This expectation has been observed (4) .
The present study reports measurements of the testosterone concentration in amniotic fluid at different gestational ages and the correlation of testosterone levels with the sex of the fetus.
MATERIALS A N D METHODS

MATERIALS
[1,2,6,7-.'H]Testosterone (85 Ci/mmol) was purchased from New England Nuclear, Boston. MA. The purity of the labeled steroid was checked periodically by column chromatography on Sephadex LH-20 (Pharmacia Fine Chemicals, Inc., Piscataway, NJ). Testosterone. dextran type 5-40, and the Tris-Cl buffer components were purchased from Sigma Chemical Co., St. Louis, MO. Scintiverse is a product of Fisher Scientific Co., St. Louis, MO. All other chemicals and solvents, obtained from common suppliers, were of analytic grade.
PROCEDURE
Amniotic fluid was withdrawn by standard amniocentesis ( 1 1) following placental localization by ultrasonography. Amniocentesis was performed during therapeutic abortion or for the purpose of diagnosing genetic abnormalities, Rh sensitization, and fetal maturity on 43 patients from whom a total of 57 samples were drawn at gestational ages varying from 14-40 weeks. Amniotic fluid was stored frozen until the time of steroid analysis.
The sex of the infants was determined either from official birth records of fetuses not aborted, from a direct examination of the abortus. or from the karyotyping of cultured amniotic fluid. The gestational age at the time of amniocentesis was determined from the last known menstrual period and confirmed by ultrasonographic measurement of fetal biparietal diameter.
Testosterone concentration was determined by radioimmunoassay using a specific antibody generated in sheep against I lnhydroxytestosterone-hemisuccinyl bovine serum albumin (12) . Details of the method applied to human serum have been published (10) . A high degree of antibody specificity eliminated the need for preliminary chromatographic isolation of extracted testosterone. Aliquots of amniotic fluid, 2.0 ml, made alkaline with 0.2 ml of 0.1 N NaOH, were extracted with 8 rnl benzene-petroleum ether (2:5): these were then taken to dryness and dissolved' in 0.1 ml buffer. Recovery of extracted testosterone averaged 86.8 k 8.2% (n = 29). All intervening steps of the assay prior to tritium counting were carried out at ice bath temperature. Steroid extracts issolved in 0.1 ml 0.05 M Tris buffer, pH 8.0, were equilibrated nitially for 1 hr with 0.1 ml antibody-buffer solution (dilution 1:7000) and subsequently for 15 hr after adding 0.1 ml of a olution of [1.2,6,7-"Hltestosterone (ca. 15,000 cpm) in buffer.
1 Unbound steroid was removed during a 20 min exposure to 0.7 ml of a suspension of dextran-coated charcoal (250 mg Norit A. 1.0 g dextran/100 ml Tris buffer). Charcoal was pelleted by centrifugation (2000 rpm x 20 min), and 0.5 ml of the supernatant solution was mixed with 4.5 ml Scintiverse. Samples were counted with a n efficiency of 28.5'70. T h e accuracy of the testosterone assay was established by measurements of known quantities of testosterone added to amniotic fluid. Distilled water usually measured zero eliminating the necessity for a blank correction.
RESULTS
Evaluations of the accuracy and precision of the testosterone radioimmunoassay applied to the analysis of amniotic fluid are Table I . Figure I presents the individual determination of amniotic fluid testosterone according to sex and gestational age. Individual determinations were combined into three groups according to gestational age: group 1, 11-20 weeks: group 11. 21-30 weeks, and group 111. 31-40 weeks. T h e mean testosterone concentrations for each group computed according to fetal sex are given in Figure 2 . Of the 14 patients comprising group I. X bore male fetuses. The mean testosterone concentration for male fetuses in this group was 198.7 pg/ml (range 93-319.8 pg/ml) and 74.1 pg/ml for female fetuscs (range 39-122.8 pg/ml). G r o u p I1 was comprised of 23 patients. 13 of whom bore male fetuses. T h e mean testosterone concentration for male fetuses was 221.5 pg/ml (range 133.6-395.0 pg/ml), and for female fetuses it was 67.7 pg/ ml (range 35.6-103.0 pg/ml). G r o u p I11 consisted of 20 patients of whom 10 bore male fetuses. T h e mean testosterone concentration for the male fetuses was 149.1 pg/ml (range 99.2-262.0 pg/ml). and for female fetuses it was 60.2 pg/ml (range 39.5-96.7 pg/ml).
T h e differences between the ;exes within each grou-p were analyzed by Student's 1-test and found to bc statistically sirnificant in ali threegroups as shown in Table 2 . Amniotic ~l u i d i e s~s t e r o n e concentrations in women bearing female fetuses were found to be similar in all three groups. However, women bearing male fctuses showed testosterone levels which varied with gestational age. being highest in group I1 patients (21-30 weeks ofgestation), and lowest in group 111 (31-40 weeks). Statistical differences could not be established between groups I and 11 males or between groups I and 111 males. but the difference between groups I1 and 111 males was significant (P < 0.025).
As shown in Figure I the highest testosterone value determined in women bearing females (122.8 pg/ml) overlapped with the lowest value from those bearing males (93 pg/ml). However, the percentage of males with values greater than 100 pg/ml was 93.55 (29 of 31). and the percentage of females with values less than I00 pg/ml was 88.5% (23 of 26). Similar comparisons made within each of the thrce groups showed overlapping values between males and females in group I having gestational ages of 20 weeks or less. but no overlap within groups I1 or 111. Patients in group 11 who bore male fetuses had the highest values observed which tended to reduce the likelihood of overlap with the female range. Thus, determination of amniotic fluid testosterone levels between 20 and 30 weeks of gestation should provide the most discriminating evaluation for the rapid antenatal diagnosis of fetal sex. The testosterone concentration of amniotic fluid can be rapidly and economically established with only a few milliliters of supernatant fluid. Correlation of the fetal sex based upon this test with the amniotic fluid karyotype could serve to further increase confidence that the analyzed cells are indeed of fetal origin. The certainty of diagnosis could be even further increased by combining the testosterone evaluation with fluorescent Y-chromatin screening of the uncultured fluid. A combination of such techniques should eliminate the possibility of diagnostic error because of maternal cell contamination.
CONCLUSION
A radioimmunoassay is presented which is suitable for determining the testosterone concentration of amniotic fluid. Assay of fluid drawn from 43 women between the 14th and 40th weeks of pregnancy demonstrated a significantly higher steroid level in fluid from women bearing male fetuses. The greatest margin of difference between male-and female-bearing women was evident between 20 and 30 weeks of gestation. This difference provides a discriminating evaluation for the rapid antenatal diagnosis of fetal sex with a low probability of error.
